Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cells

Journal of Gene Medicine

Volumn 7, Issue 12, 2005, Pages 1555-1564

  Carrabino, Salvatore ^a   Di Gioia, Sante ^a   Copreni, Elena ^a   Conese, Massimo ^a,b  

^a Institute for the Experimental Treatment of Cystic Fibrosis   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Albumin; CF transmembrane conductance regulator (CFTR); Cystic fibrosis (CF); Gene transfer; Polyethylenimine; Sputum

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; LACTATE DEHYDROGENASE; LUCIFERASE; POLYETHYLENEIMINE; SERUM ALBUMIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL CULTURE; CELL POLARITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOTOXICITY; ENZYME ASSAY; EPIFLUORESCENCE MICROSCOPY; EPITHELIUM CELL; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SPACE; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT MUCOSA; SPUTUM;

CELL LINE; CYSTIC FIBROSIS; DNA; GENE EXPRESSION; GENE THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; L-LACTATE DEHYDROGENASE; LUCIFERASES; MICROSCOPY, FLUORESCENCE; POLYETHYLENEIMINE; RESPIRATORY MUCOSA; SERUM ALBUMIN; SPUTUM; TRANSFECTION; TRANSGENES;

EID: 29744441781     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.799     Document Type: Article

References (47)

1. Riordan JR, Rommers J, Kerem B, Alon N, Rozmahel R. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1073.
2. Davies JC, Geddes DM, Alton EWFW. Gene therapy for cystic fibrosis. J Gene Med 2001; 3: 409-417.
3. Dunlop DD, Maggi A, Soria MR, Monaco L. Nanoscopic structure of DNA condensed for gene delivery. Nucleic Acids Res 1997; 25: 3095-3101.
4. Ferrari S, Pettenazzo A, Garbati N, et al. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy. Biochim Biophys Acta 1999; 1447: 219-225.
5. Bragonzi A, Conese M. Non-viral approach toward gene therapy of cystic fibrosis lung disease. Curr Gene Ther 2002; 2: 295-305.
6. Lemkine GF, Demeneix BA. Polyethylenimines for in vivo gene delivery. Curr Opin Mol Ther 2001; 3: 178-182.
7. Plank C, Mechtler K, Szoka FC, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.
8. Kitson C, Angel B, Judd D, et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther 1999; 6: 534-546.
9. Ferrari S, Kitson C, Farley R, et al. Mucus altering agents as adjunct for nonviral gene transfer to airway epithelium. Gene Ther 2001; 8: 1380-1386.
10. Stern M, Caplen NJ, Browning JE, et al. The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther 1998; 5: 91-98.
11. Rosenecker J, Naundorf S, Gersting SW, et al. Interaction of bronchoalveolar lavage fluid with polyplexes and lipoplexes: analysing the role of proteins and glycoproteins. J Gene Med 2003; 5: 49-60.
12. Perricone MA, Rees DD, Sacks CR, et al. Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells. Hum Gene Ther 2000; 11: 1997-2008.
13. Virella-Lowell I, Poirier A, Chesnut KA, Brantly M, Flotte TR. Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients. Gene Ther 2000; 7: 1783-1789.
14. Sanders NN, Van Rompaey E, De Smedt SC, Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am J Respir Crit Care Med 2001; 164: 486-493.
15. Lethem MI, James SL, Marriott C, Burke JF. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur Respir J 1990; 3: 19-23.
16. Sheils CA, Kas J, Travassos W, et al. Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol 1996; 148: 919-927.
17. Sanders NN, De Smedt SC, Demeester J. Mobility and stability of gene complexes in biogels. J Control Release 2003; 87: 117-129.
18. Sanders NN, De Smedt SC, Cheng SH, Demeester J. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. Gene Ther 2002; 9: 363-371.
19. Simoes S, Slepushkin V, Pires P, et al. Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim Biophys Acta 2000; 1463: 459-469.
20. Orson FM, Song L, Gautam A, et al. Gene delivery to the lung using protein/polyethylenimine/plasmid complexes. Gene Ther 2002; 9: 463-471.
21. Bragonzi A, Boletta A, Biffi A, et al. Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs. Gene Ther 1999; 6: 1995-2004.
22. Moyer BD, Loffing J, Schwiebert EM, et al. Membrane trafficking of the cystic fibrosis gene product, cystic fibrosis transmembrane conductance regulator, tagged with green fluorescent protein in Madin-Darby canine kidney cells. J Biol Chem 1998; 273: 21 759-21 768.
23. Gruenert DC, Basbaum CB, Welsh MJ, Finkbeiner WE, Nadel JA. Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci U S A 1988; 85: 5951-5955.
24. Yankaskas JR, Haizlip JE, Conrad M, et al. Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am J Physiol 1993; 264: C1219-C1230.
25. Olsen JC, Johnson LG, Stutts MJ, et al. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum Gene Ther 1992; 3: 253-266.
26. Moyer BD, Stanton BA. Analysis of CFTR trafficking and polarization using green fluorescent protein and confocal microscopy. Methods Mol Med 2002; 70: 217-227.
27. Meng Q-H, Robinson D, Jenkins GR, McAnulty RJ, Hart SL. Efficient transfection of non-proliferating human airway epithelial cells with a synthetic vector system. J Gene Med 2004; 6: 210-221.
28. Crawford I, Maloney PC, Zeitlin PL, et al. Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc Natl Acad Sci U S A 1991; 88: 9262-9266.
29. Denning GM, Ostetgaard LS, Cheng SH, Smith AE, Welsh MJ. Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J Clin Invest 1992; 89: 339-349.
30. Chuang VT, Kragh-Hansen U, Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 2002; 19: 569-577.
31. Pilewski JM. Gene therapy for airway diseases: continued progress toward identifying and overcoming barriers to efficiency. Am J Respir Cell Mol Biol 2002; 27: 117-121.
32. Jiang C, O'Connor S, Fang SL, et al. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum Gene Ther 1998; 9: 1531-1542.
33. Matsui H, Johnson LG, Randell SH, Boucher RC. Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem 1997; 272: 1117-1126.
34. Schnitzer JE. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am J Physiol 1992; 262: H246-H254.
35. John TA, Vogel SM, Minshall RD, et al. Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung. J Physiol 2001; 533: 547-559.
36. Rhaese S, von Briesen H, Rubsamen-Waigmann H, Kreuter J, Langer K. Human serum albumin-polyethylenimine nanoparticles for gene delivery. J Control Release 2003; 92: 199-208.
37. Kopatz I, Remy JS, Behr JP. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J Gene Med 2004; 6: 769-776.
38. Conese M, Copreni E, Di Gioia S, De Rinaldis P, Fumarulo R. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. J Cystic Fibrosis 2003; 2: 129-135.
39. Denning GM, Anderson MP, Amara JF, et al. Processing of mutant cystic fibrosis transmembrane regulator is temperature-sensitive. Nature 1992; 358: 761-764.
40. Kopito RR. Biosynthesis and degradation of CFTR. Physiol Rev 1999; 79: S167-S173.
41. Dalemans W, Barbry P, Champigny G, et al. Altered chloride ion channel kinetics associated with the ΔF 508 cystic fibrosis mutation. Nature 1991; 354: 526-528.
42. Haws CM, Nepomuceno IB, Krouse ME, et al. Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 1996; 270: C1544-1555.
43. Hwang TC, Wang F, Yang IC, Reenstra WW. Genistein potentiates wild-type and delta F508-CFTR channel activity. Am J Physiol 1997; 273: C988-C998.
44. Bertrand CA, Frizzell RA. The role of regulated CFTR trafficking in epithelial secretion. Am J Physiol Cell Physiol 2003; 285: C1-C18.
45. Auriche C, Carpani D, Conese M, et al. Functional human CFTR produced by a stable minichromosome. EMBO Rep 2002; 3: 862-868.
46. Rudolph C, Lausier J, Naundorf S, Muller RH, Rosenecker J. In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers. J Gene Med 2000; 2: 269-278.
47. Bragonzi A, Dina G, Villa A, et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 2000; 7: 1753-1760.